-
1دورية أكاديمية
المؤلفون: Padi, Sathish K.R., Luevano, Libia A., An, Ningfei, Pandey, Ritu, Singh, Neha, Song, Jin H., Aster, Jon C., Yu, Xue-Zhong, Mehrotra, Shikhar, Kraft, Andrew S.
مرشدي الرسالة: Univ Arizona, Ctr Canc, Univ Arizona, Dept Cellular & Mol Med
مصطلحات موضوعية: PIM kinase, T-ALL, ETP-ALL, tyrosine kinase inhibitor, ponatinib
الإتاحة: http://hdl.handle.net/10150/624055Test
http://arizona.openrepository.com/arizona/handle/10150/624055Test -
2دورية أكاديمية
المؤلفون: Song, Jin H., Padi, Sathish K. R., Luevano, Libia A., Minden, Mark D., DeAngelo, Daniel J., Hardiman, Gary, Ball, Lauren E., Warfel, Noel A., Kraft, Andrew S.
مرشدي الرسالة: Univ Arizona, Dept Cellular & Mol Med, Univ Arizona, Ctr Canc
مصطلحات موضوعية: insulin, IGF1, IRS1, Pim kinase, Pim kinase inhibitor
الإتاحة: http://hdl.handle.net/10150/614947Test
http://arizona.openrepository.com/arizona/handle/10150/614947Test -
3دورية أكاديمية
المؤلفون: Song, Jin H., Kang, Hyun-Jin, Luevano, Libia A., Gokhale, Vijay, Wu, Kui, Pandey, Ritu, Sherry Chow, H.-H., Hurley, Laurence H., Kraft, Andrew S.
المساهمون: National Cancer Institute, U.S. Department of Defense
المصدر: Cell Chemical Biology ; volume 26, issue 8, page 1110-1121.e4 ; ISSN 2451-9456
مصطلحات موضوعية: Clinical Biochemistry, Drug Discovery, Pharmacology, Molecular Biology, Molecular Medicine, Biochemistry
الإتاحة: https://doi.org/10.1016/j.chembiol.2019.04.009Test
https://api.elsevier.com/content/article/PII:S2451945619301400?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2451945619301400?httpAccept=text/plainTest -
4دورية أكاديمية
المؤلفون: Song, Jin H, Singh, Neha, Luevano, Libia A, Padi, Sathish K R, Okumura, Koichi, Olive, Virginie, Black, Stephen M, Warfel, Noel A, Goodrich, David W, Kraft, Andrew S
المساهمون: Univ Arizona, Dept Cellular & Mol Med, Univ Arizona, Ctr Canc, Univ Arizona, Dept Physiol, Univ Arizona, Dept Med
المصدر: Molecular cancer therapeutics
العلاقة: Song, J. H., Singh, N., Luevano, L. A., Padi, S. K., Okumura, K., Olive, V., . & Kraft, A. S. (2018). Mechanisms behind resistance to PI3K Inhibitor treatment induced by the PIM kinase. Molecular cancer therapeutics, 17(12), 2710-2721.; http://hdl.handle.net/10150/631765Test; MOLECULAR CANCER THERAPEUTICS
-
5دورية أكاديمية
المؤلفون: Turbyville, Thomas J., Wijeratne, E. M. Kithsiri, Liu, Manping X., Burns, Anna M., Seliga, Christopher J., Luevano, Libia A., David, Cynthia L., Faeth, Stanley H., Whitesell, Luke, Gunatilaka, A. A. Leslie
المصدر: Journal of Natural Products ; volume 69, issue 2, page 178-184 ; ISSN 0163-3864 1520-6025
-
6دورية
المؤلفون: J. Turbyville, Thomas, M. Kithsiri Wijeratne, E., X. Liu, Manping, M. Burns, Anna, J. Seliga, Christopher, A. Luevano, Libia, L. David, Cynthia, H. Faeth, Stanley, Whitesell, Luke, A. Leslie Gunatilaka, A.
المصدر: Journal of Natural Products; February 2006, Vol. 69 Issue: 2 p178-184, 7p
-
7دورية
المؤلفون: Padi, Sathish Kumar Reddy, Luevano, Libia A, An, Ningfei, Pandey, Ritu, Singh, Neha, Song, Jin H, Aster, Jon C., Yu, Xue-Zhong, Mehrotra, Shikhar, Kraft, Andrew S
المصدر: Blood; December 2016, Vol. 128 Issue: 22 p2742-2742, 1p